Kinesins in the mitotic spindle play major roles in determining spindle shape, size, and bipolarity, although specific regulation of these kinesins at distinct locations on the spindle is poorly understood. So that the forces that are required for spindle bipolarity are balanced, microtubuledepolymerizing kinesins are tightly regulated. Aurora B kinase phosphorylates the neck regions of the kinesin-13 family microtubule depolymerases Kif2a and mitotic centromere-associated kinesin (MCAK) and inhibits their depolymerase activities. How they are reactivated and how this is controlled independently on different kinetochore fibers is unknown. We show that inner centromere Kin-I stimulator (ICIS), which stimulates the related depolymerase MCAK, can reactivate Kif2a after Aurora B inhibition. When antibodies that block the ability of ICIS to activate Kif2a are injected into cells, monopolar spindles are generated. This phenotype is rescued by coinjection of anti-Nuf2 antibodies. We have performed a structure-function analysis of the ICIS protein and find that the N terminus of ICIS binds Aurora B and its regulators INCENP and TD60, whereas a central region binds MCAK, Kif2a, and microtubules, suggesting a scaffold function for ICIS. These data argue that ICIS and the chromosomal passenger complex (CPC) regulate Kif2a depolymerase activity.
Results and Discussion
The C Terminus of ICIS Reverses Aurora B Inhibition of Kif2a In Vitro The microtubule depolymerase activities of Kif2a and mitotic centromere-associated kinesin (MCAK) are inhibited through phosphorylation by Aurora kinases [1] [2] [3] . On MCAK, this phosphorylation event has been mapped to the neck region, which lies proximal to the kinesin domain. Not only does Aurora regulate MCAK activity, but it also regulates its localization on the spindle [1, 3, 4] . Surprisingly, phosphorylated MCAK is often found at locations where MCAK activity is required [5, 6] . Therefore, there must be tight spatial regulation of the activity of these proteins in their different subcellular locations, as well as mechanisms to reactivate depolymerase activity after Aurora phosphorylation.
We adapted a system to measure Kif2a microtubule depolymerase activity in vitro [1] . Rhodamine-labeled taxol-stabilized microtubules were incubated with recombinant Kif2a aa 118-530, which is the minimal domain required for depolymerase activity (Kif2a minimal domain). Although this protein construct was cloned from the human sequence, it is 93% identical to the Xenopus sequence ( Figure S1 available online). Titration of Kif2a into the reaction shows concentrationdependent depolymerase activity with linear responses and saturation of activity after 40 nM ( Figure 1A ).
Because inner centromere Kin-I stimulator (ICIS) was shown to regulate MCAK microtubule depolymerase activity in vitro, we tested whether it could similarly regulate Kif2a. Four truncation proteins were made from the full-length Xenopus ICIS protein: ICIS A (ICIS ), B (ICIS ), C (ICIS ) and D (ICIS 992-1338 ) ( Figure 1B ). The C fragment contains the protein's F box, and the D fragment is the protein's coiledcoil domain. All proteins were expressed in E. coli as 6-His fusion proteins and purified on Ni 2+ columns. An amount of 50 nM Kif2a depolymerized most microtubules by 7 min (Figures 1C and Figure S2) . Surprisingly, none of the ICIS fragments could stimulate this activity ( Figures 1C and S2 and data not shown).
Phosphorylation of Kif2a by Aurora B for 15 min before the addition of microtubules inhibited Kif2a depolymerase activity ( Figures 1C and S2 ). To test its effects on phosphorylated Kif2a, we then added equimolar amounts of ICIS fragments to the reactions after Aurora B phosphorylation, and depolymerase activity was measured. The ICIS D fragment (the C-terminal, coiled-coil region) did not have an effect on Kif2a alone, but it could restore Kif2a activity after it was first inhibited by Aurora B phosphorylation ( Figure 1C ). The other fragments had no detectable effect on Kif2a activity (data not shown). A titration of ICIS D into this reaction demonstrates that Kif2a activity increases with ICIS D concentration, and activity approaches that of unphosphorylated Kif2a at stoichiometric amounts of ICIS D ( Figure 1D ). It appears that Kif2a cannot be stimulated above the unphosphorylated amount of activity because adding five or ten times stoichiometric amounts of ICIS did not activate Kif2a above its uninhibited activity ( Figure S3 ). These data suggest that ICIS binding restores the activity of Kif2a that has been inhibited by Aurora B phosphorylation.
ICIS could reactivate Kif2a by removing the inhibitory phosphorylation or by direct stimulation. Aurora B inhibits MCAK activity by phosphorylation on serine 196 in the neck region of the protein. We found an equivalent site in the neck region of Kif2a, serine 132, and tested whether this site was phosphorylated by Aurora B ( Figure S4A ). Unfortunately, recombinant Kif2a-S132A mutant protein has no depolymerase activity, making it impossible to conclusively show that this is the key inhibitory site on Kif2a. We made a polyclonal antibody against phospho-S132 of Kif2a. Antibody recognition of Kif2a in vitro required prior phosphorylation by Aurora kinase, demonstrating that this antibody is phosphospecific ( Figures  1E and S4B) . Moreover, the antibody recognizes a protein at *Correspondence: pts7h@virginia.edu 3 These authors contributed equally to this work w85 kD in Xenopus M phase extracts containing phosphatase inhibitors, which is the expected size of Xenopus Kif2a. To determine whether ICIS is dephosphorylating Kif2a to reactivate activity, we immunoblotted the recombinant microtubule depolymerase reaction with the pS132 antibody ( Figure 1E ). Phosphorylation of the presumptive inhibitory site did not decrease when ICIS stimulates activity. These data argue that ICIS D activates phosphorylated Kif2a not by dephosphorylation but by direct binding.
To characterize the interactions of ICIS D in vivo, we covalently linked recombinant ICIS D to Sepharose beads. These beads were incubated in mitotic Xenopus extracts, and associated proteins were probed by immunoblot. As expected from biochemical experiments, ICIS D binds MCAK and Kif2a ( Figure 1F ). In addition, ICIS D bound Aurora B and its activators INCENP and TD-60. ICIS D beads were also incubated with purified recombinant Kif2a, which showed that ICIS D and Kif2a interact directly in vitro ( Figure 1G ).
These data argue for dual regulation of kinesin-13 microtubule depolymerases. First, Aurora B kinase phosphorylates the neck domain of these proteins to inhibit depolymerase activity. Second, a coiled-coil domain on ICIS then reactivates inhibited Kif2a. It is likely that MCAK is regulated in the same way, even though ICIS has been demonstrated to stimulate intrinsic MCAK depolymerase activity [7] . We contend that the purified MCAK used in the original experiments contained both inhibited and uninhibited protein. MCAK purified from baculovirus (which was used in the original experiments) is phosphorylated on S196 and, thus, is partially inhibited ( Figure S5 ).
MCAK from baculovirus is not fully phosphorylated, given that we could more than double the pS196 staining after incubation with Aurora B kinase (data not shown). Because we used recombinant Kif2a from bacteria (which is not phosphorylated), it can only be activated by ICIS after Aurora B phosphorylation. However, it is important to test this idea in the future because another important difference between the two experiments is that we used the catalytic portion of Kif2a, whereas previous experiments were performed with full-length MCAK.
Anti-ICIS Injection Results in a Monopolar Spindle Phenotype
To determine whether the C terminus of ICIS regulates kinesin-13 s in vivo, we generated a polyclonal antibody against ICIS D ( Figure S6 ). After affinity purification, this antibody predominantly recognized a protein at the expected molecular weight for ICIS (160 kD). Several smaller bands are also recognized by the antibody, but it only depletes the 160 kD band, suggesting that ICIS is the only protein that is recognized in the native conformation. The antibody against the ICIS D region was added to a microtubule depolymerase reaction, and the antibody blocked the reactivation of Kif2a by ICIS D (Figure 2A) .
To determine the importance of the C terminus of ICIS in cultured cells, we injected this antibody into prophase Xenopus S3 cells stably expressing GFP-tubulin ( Figure 2B and Movie S1). Whereas control IgG-injected cells assemble bipolar spindles by 6-10 min ( Figure 2B (Movie S2). This result phenocopies siRNA knockdown of Kif2a in U2OS cells [8] , although there is no evidence to support Kif2a's role in bipolarity in Xenopus cells. The injected antibodies primarily localize to spindle poles ( Figure S7 ). We note that the requirement for ICIS D may not be universal, given that this monopolar spindle phenotype could not be recapitulated in Xenopus extracts (data not shown). Because an antibody that blocks the reactivation activity of ICIS also generates spindle defects, these data argue that ICIS reactivation of kinesin-13 s is required for proper spindle function.
Monopolar Spindles Generated by a-ICIS Injection Are Rescued by Coinjecting a-Nuf2 Monopolar spindles can be generated by defects in centrosome separation, regulators of microtubule dynamics (Kif2a and Aurora A), or inhibition of kinesins that crosslink pole-topole microtubules (Eg-5 and KSP-1). In the a-ICIS-injected cells, we see separation of poles before nuclear envelope breakdown, arguing for proper centrosome segregation. Previous experiments have shown that inhibition of a class of proteins that regulate K fiber dynamics can be rescued by coinhibition of kinetochore-microtubule binding, whereas monopolarity generated by Eg-5 inhibition is not rescued by this treatment [8] . To classify the monopolarity generated by anti-ICIS injection, we coinjected a-Nuf2 antibodies along with a-ICIS D antibodies into GFP-tubulin-expressing S3 cells (n = 6) ( Figure 3 and Movie S3). We found that coinjection did indeed rescue spindle bipolarity, and the cells proceeded through mitosis with a ''cut'' phenotype, which is expected in a cell with defective kinetochores. These data suggest that knocking out the kinesin-13 reactivating function of ICIS in Xenopus cells may generate monopolarity through a similar pathway as siRNA knockdown of Kif2a in U2OS cells.
Kif2a Is Localized to Centromeres in Xenopus Cells
ICIS and MCAK are localized to both centromeres and spindle poles in Xenopus [7, 9, 10] . In human U2OS cells, Kif2a localizes to spindle poles during mitosis and Kif2b localizes to centromeres [11] . Xenopus appears to only have a gene for Kif2a. We generated a polyclonal antibody against Kif2a to determine its localization in Xenopus cells. The Kif2a antibody recognized a single band around 85 kD, the expected size in Xenopus ( Figure S8A ). When the antibody was used for immunofluorescence in Xenopus cells, it labeled spindle poles throughout mitosis ( Figure S8B , arrows). Kif2a is also localized to most centromeres during prometaphase and to a smaller number of centromeres at metaphase ( Figure S8B, inset) . Thus, Kif2a, MCAK, and ICIS concentrate at the same cellular locations in Xenopus cells.
ICIS Interacts with Aurora B Kinase, Its Substrates, and Its Activators ICIS binds microtubules and coimmunoprecipitates with members of the chromosomal passenger complex (CPC) and MCAK [7] . We mapped these interactions by covalently attaching the four ICIS fragments to Sepharose beads, incubating them in a Xenopus CSF-arrested extract and probing the interacting proteins by immunoblot ( Figure 4A ). We found that the N terminus of ICIS (ICIS A) interacts with Aurora B and with its activators INCENP and TD-60 [12] . A middle region (ICIS B fragment) interacts with both Kif2a and MCAK ( Figure 4A ). These data show that ICIS interacts with Aurora B kinase, its activators, and two substrates, Kif2a and MCAK.
To determine which domain of ICIS is responsible for microtubule binding, we added taxol to Xenopus M phase extracts and pelleted microtubules and their interacting proteins through sucrose cushions. Microtubules pelleted ICIS B and ICIS C ( Figure 4B ). ICIS C also bound purified taxol-stabilized microtubules; however, ICIS B did not, and there was a weak interaction with ICIS D. (Figure 4B 0 ).
We visualized complexes of ICIS C and purified rhodaminelabeled microtubules by fluorescence microscopy. ICIS C bundled microtubules ( Figure 4C ). The bundles appear to be aggregations of laterally associated microtubules, and the bundles are longer than the individual microtubules used in the assay. The other fragments of ICIS did not bundle microtubules.
Previous to this study, it was not understood why microtubule depolymerases would be phosphorylated on inhibitory sites in cellular locations where their activity is required [1, 3, 6] . This work reveals a novel form of regulation of these kinesins, whereby phosphorylated and inhibited depolymerases can be reactivated by ICIS without being dephosphorylated ( Figure 4D ). It remains to be seen whether phosphatase activity also plays a role in the reactivation of kinesin-13 family members. Our structure function analysis of ICIS implicates it as a potential scaffold, which could bring together the activator and the inhibitors of kinesin-13 depolymerases ( Figure 4D ) to facilitate tight spatial and temporal regulation of depolymerase activity in the mitotic spindle.
Experimental Procedures Protein Expression and Antibody Production
The full-length Xenopus laevis ICIS cDNA clone was obtained from R. Ohi (Vanderbilt University, Nashville, TN). A series of bacterial expression constructs were generated by PCR and subcloned into pET30 with 5 0 Nco I and 3 0 Not I overhangs. The following primers were used to clone the different fragments of ICIS into pET30: for ICIS A (ICIS ICIS fragments were expressed in the E. coli strain BL21 (DE3 pLysS, Novagen). All 6His-tagged proteins were purified on Ni 2+ -NTA agarose as instructed by the manufacturer (QIAGEN, Chatsworth, CA). Glutathione S-transferase (GST)-tagged proteins were purified on glutathione agarose beads. Purified proteins were covalently coupled to CNBr-activated Sepharose beads according to the manufacturer's instructions (Amersham Biosciences, Piscataway, NJ).
Antibodies were produced from the 6His-ICIS D recombinant protein by Covance Research Products (Denver, PA). Antibodies raised against 6His-tagged proteins were purified over corresponding GST-tagged protein columns and vice versa. Affinity-purified antibodies were dialyzed into PBS.
The cDNA clone of human Kif2a (BC033842) was purchased from Open Biosystems (Huntsville, AL). Kif2a aa 530-679 was cloned into pET30a by using primers with the sequences 5 0 -GCGGATCCCGGATGCCAACTGCTG CTGGTG-3 0 and 5 0 -GATCGGAATTCGTTAAAGGGCACGGGGTCTCTT-3 0 to generate the construct Pet30a-Kif2a (530-679). Recombinant protein was expressed in (pLysS) BL21 bacteria for 4 hr at room temperature. This 6His-tagged protein was purified with conventional nickel bead affinity (Qaigen) according to the manufacturer's instructions, and the protein was used to make a polyclonal rabbit antibody (Covance, Denver, PA).
Kif2a minimal domain (aa 118-530) was cloned into pET30a as well by using primers with the sequences 5 0 -GCGGATCCCGGATGGCAAAAAAGG AATTTGG and 5 0 -GATCGCGGCCGCTTATGGATCTACAGTCAATTCTTT-3 0 and was expressed and purified as above. The protein was dialyzed into supplemented kinase buffer (20 mM tris [pH 7.5], 1 mM MgCl2, 25 mM KCl, 50 mM NaCl, 1 mM DTT, and 5% glycerol). The pS132 antibody was raised against the peptide C-GPPSRRKpSN (synthesized in Yale's W.M. Keck Protein Core facility, New Haven, CT). The peptide was attached to KLH with SMCC (Pierce), and the resulting conjugate was injected into rabbits to produce polyclonal serum (Covance). For affinity purification, both phospho and nonphospho columns were generated with Sulfo-beads (Pierce) according to the manufacturer's instructions. Antibodies were affinity purified first by counterselection on the nonphosphopeptide before being affinity purified on the phosphopeptide column [13] . Immunoblots were performed as previously described [14] , with the exception that, with phosphopeptide antibodies, the PVDF membrane was blocked in 3% BSA.
Visual Microtubule Depolymerase Assays
Microtubule depolymerase assays for Kif2a were performed as described for MCAK [1] with 50 nM Kif2a minimal domain, 50 nM ICIS fragments (unless otherwise noted), and 1 nM Aurora B/INCENP in the assays. In brief, the proteins were incubated with microtubules in CSF-XB (10 mM K-HEPES [pH 7.7], 100 mM KCl, 2 mM MgCl2, 0.1 CaCl2, 50 mM sucrose, and 5 mM EGTA), with 2 mM ATP, 1 mM DTT, and 15 mM taxol. At the time points indicated, 1 ul samples were taken, diluted into 5 ul fix solution, and spotted onto a slide. Four fields were taken per time point with a 1003 objective. The images were acquired as above and analyzed with Metavue software.
Microtubule Pelleting Assays
For microtubule pelleting in CSF extracts, we treated fresh extracts with either 10 mM Taxol or 10 mg/ml Nocodazole (negative control) for 30 min at room temperature. Microtubules and associated proteins were spun through 1 M sucrose cushion. For microtubule pelleting in vitro, we incubated preformed taxol-stabilized pure microtubules (Cytoskeleton, Denver, CO) with different ICIS mutants at room temperature for 30 min. The reaction mixtures were pelleted through 1 M sucrose cushion, washed, and detected by S-protein-HRP or a-tubulin antibody.
Cell Injections
Xenopus laevis S3 cells stably transfected with a-tubulin-GFP were used for microinjections. Cells were kept at 23 C in 70% Leibovitz's L-15 medium containing 15% FBS, L-Glutamine, and penicillin-streptomycin. For microscopy, cells were grown on glass coverslips. Cells were injected with the following antibodies diluted in PBS: rabbit polyclonal anti-ICIS C terminus at a needle concentration of 9 mg/ml and anti-xNuf2 at a needle concentration of 4 mg/ml. Anti-xNuf2 antibodies were characterized previously [15] . Control cells were 
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